Carrie Haslam - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Carrie Haslam's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Carrie Haslam
Verified
Editor, Drug Target Review
Beats
dating., spirituality,parenting addiction, recovery/mental health, divorce human interest, substance abuse, politics women's health, midlife, education
Content
By Carrie Haslam Verified| Drug Target Review Verified Posted: 14 March 2025 | Drug Target Review | Insilico Medicine’s AI-designed drug for idiopathic pulmonary fibrosis (IPF), Rentosertib, has been granted an official name by USAN. This is the first drug where both the target and compound were discovered using generative AI, marking a major milestone in AI-driven drug development.
By Carrie Haslam Verified| Drug Target Review Verified Posted: 13 March 2025 | Drug Target Review | A commonly prescribed diabetes medication could significantly enhance long-term recovery prospects for cancer patients by reducing their risk of heart failure, a new study from the University of East Anglia (UEA) reveals. Protecting the heart during cancer treatmentCancer treatments, particularly chemotherapy, often lead to severe cardiovascular complications that substantially impact patient health and quality of life.
By Carrie Haslam Verified| Drug Target Review Verified Posted: 14 March 2025 | Drug Target Review | Insilico Medicine’s AI-designed drug for idiopathic pulmonary fibrosis (IPF), Rentosertib, has been granted an official name by USAN. This is the first drug where both the target and compound were discovered using generative AI, marking a major milestone in AI-driven drug development.
Company Info
Drug Target Review
European Pharmaceutical Review is a prominent publication in the pharmaceutical industry, based in the UK. It focuses on drug analysis, formulation, delivery, manufacturing, and regulation, providing a platform for industry professionals to stay informed about the latest developments. The publication features bi-monthly issues that include contributions from leading pharmaceutical scientists and business experts, along with interviews and industry updates. The company offers various advertising and marketing opportunities, including print and digital ads, events, and social media campaigns, aimed at helping businesses connect with key decision-makers in the pharmaceutical and life sciences sectors. European Pharmaceutical Review also maintains a strong digital presence, providing access to news, articles, whitepapers, and webinars on topics such as genetics, chromatography, and drug manufacturing. With a substantial readership and online engagement, it serves as a vital resource for professionals in the industry.
United Kingdom, United Kingdom
+44 19 5956 3311
Founded: 1996